Upgrade to SI Premium - Free Trial

UBS Upgrades Medpace (MEDP) to Buy

February 15, 2024 2:18 AM
UBS analyst John Sourbeer upgraded Medpace (NASDAQ: MEDP) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Upgrades